Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TRI MAG GEL SUSPENSION is an oral antacid suspension developed by National Pharmaceutical. It is a fixed-dose combination containing the active ingredients aluminium hydroxide and magnesium trisilicate. The formulation is indicated for the symptomatic relief of hyperacidity, heartburn, indigestion, and dyspepsia associated with gastric and duodenal ulcers or gastritis. It works by chemically neutralizing gastric hydrochloric acid in the stomach, thereby raising the intragastric pH and reducing pepsin activity. This local, non-systemic action helps protect the gastrointestinal mucosa and alleviate acid-induced irritation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aluminium hydroxide + magnesium trisilicate.